FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073996865> ?p ?o ?g. }

• W2073996865 abstract "To determine whether single-modality therapy is optimal management for patients with Stage III-IV Hodgkin's disease.All patients with advanced (Stage III and IV) Hodgkin's disease treated at the University of Florida from 1964 through 1989 (n = 141) were studied retrospectively for factors predictive of good outcome with single-modality therapy. Treatment modalities varied and were distributed as follows: combined-modality therapy (CMT), 55 patients; chemotherapy alone (CX), 50 patients; and radiotherapy alone (RT), 36 patients.Ten-year rates of freedom from relapse and overall survival for all Stage III patients were 66% and 59% compared with 36% and 35% for Stage IV patients. The RT subset was highly selected with the majority of patients having nonbulky Stage IIIA disease. Within the RT group, multivariate analysis identified the degree of splenic involvement and age as the factors most associated with freedom from relapse. In patients treated with CX, multivariate analysis identified bulky tumor (maximum transverse tumor dimension > 6 cm) as the most important prognostic factor for relapse. In patients without bulky disease (< or = 6 cm), the probabilities of freedom from relapse and overall survival at 10 years, respectively, according to treatment group were 53% and 58% for RT patients, 60% and 56% for CX patients, and 83% and 71% for CMT patients. For patients without bulky disease, the probability of freedom from relapse was significantly better for the CMT group than for CX patients (p = 0.03) or RT patients (p = 0.04), but there was no statistical difference in overall survival among the three groups. In patients with bulky disease (> 6 cm), the probabilities of freedom from relapse and overall survival at 10 years were 44% and 45% for RT patients, 9% and 0% for CX patients, and 72% and 58% for CMT patients. Freedom from relapse and overall survival were significantly better (p = 0.0001) for CMT patients compared with CX patients. Fatal hematopoietic disorders developed in 10 patients: 2 of 36 RT patients, 2 of 50 CX patients, and 6 of 55 CMT patients. Nine patients had received chemotherapy, and eight had six or more cycles of alkylator-based chemotherapy.This retrospective study suggests that combined-modality therapy is preferable to single-modality therapy in the majority of patients with advanced Hodgkin's disease." @default.
• W2073996865 created "2016-06-24" @default.
• W2073996865 creator A5024449165 @default.
• W2073996865 creator A5046021449 @default.
• W2073996865 creator A5071374686 @default.
• W2073996865 date "1997-06-01" @default.
• W2073996865 modified "2023-09-24" @default.
• W2073996865 title "Is combined modality therapy necessary for advanced Hodgkin's disease?" @default.
• W2073996865 cites W1754052230 @default.
• W2073996865 cites W1828835859 @default.
• W2073996865 cites W1956400930 @default.
• W2073996865 cites W1970648719 @default.
• W2073996865 cites W1979300931 @default.
• W2073996865 cites W1986777765 @default.
• W2073996865 cites W1991550939 @default.
• W2073996865 cites W2000149854 @default.
• W2073996865 cites W2004073963 @default.
• W2073996865 cites W2006653708 @default.
• W2073996865 cites W2044066622 @default.
• W2073996865 cites W2054878443 @default.
• W2073996865 cites W2055310422 @default.
• W2073996865 cites W2065065060 @default.
• W2073996865 cites W2065620512 @default.
• W2073996865 cites W2073286025 @default.
• W2073996865 cites W2109533003 @default.
• W2073996865 cites W2165308914 @default.
• W2073996865 cites W2246556650 @default.
• W2073996865 cites W2253746538 @default.
• W2073996865 cites W2255027144 @default.
• W2073996865 cites W2255204672 @default.
• W2073996865 cites W2271361349 @default.
• W2073996865 cites W2271385855 @default.
• W2073996865 cites W2338057729 @default.
• W2073996865 cites W2411131241 @default.
• W2073996865 cites W2796537448 @default.
• W2073996865 cites W2796700885 @default.
• W2073996865 doi "https://doi.org/10.1016/s0360-3016(97)00115-6" @default.
• W2073996865 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9231683" @default.
• W2073996865 hasPublicationYear "1997" @default.
• W2073996865 type Work @default.
• W2073996865 sameAs 2073996865 @default.
• W2073996865 citedByCount "3" @default.
• W2073996865 crossrefType "journal-article" @default.
• W2073996865 hasAuthorship W2073996865A5024449165 @default.
• W2073996865 hasAuthorship W2073996865A5046021449 @default.
• W2073996865 hasAuthorship W2073996865A5071374686 @default.
• W2073996865 hasConcept C126322002 @default.
• W2073996865 hasConcept C141071460 @default.
• W2073996865 hasConcept C143998085 @default.
• W2073996865 hasConcept C146357865 @default.
• W2073996865 hasConcept C151730666 @default.
• W2073996865 hasConcept C2776694085 @default.
• W2073996865 hasConcept C2779134260 @default.
• W2073996865 hasConcept C3020606620 @default.
• W2073996865 hasConcept C38180746 @default.
• W2073996865 hasConcept C509974204 @default.
• W2073996865 hasConcept C71924100 @default.
• W2073996865 hasConcept C86803240 @default.
• W2073996865 hasConcept C90924648 @default.
• W2073996865 hasConceptScore W2073996865C126322002 @default.
• W2073996865 hasConceptScore W2073996865C141071460 @default.
• W2073996865 hasConceptScore W2073996865C143998085 @default.
• W2073996865 hasConceptScore W2073996865C146357865 @default.
• W2073996865 hasConceptScore W2073996865C151730666 @default.
• W2073996865 hasConceptScore W2073996865C2776694085 @default.
• W2073996865 hasConceptScore W2073996865C2779134260 @default.
• W2073996865 hasConceptScore W2073996865C3020606620 @default.
• W2073996865 hasConceptScore W2073996865C38180746 @default.
• W2073996865 hasConceptScore W2073996865C509974204 @default.
• W2073996865 hasConceptScore W2073996865C71924100 @default.
• W2073996865 hasConceptScore W2073996865C86803240 @default.
• W2073996865 hasConceptScore W2073996865C90924648 @default.
• W2073996865 hasLocation W20739968651 @default.
• W2073996865 hasLocation W20739968652 @default.
• W2073996865 hasOpenAccess W2073996865 @default.
• W2073996865 hasPrimaryLocation W20739968651 @default.
• W2073996865 hasRelatedWork W132604569 @default.
• W2073996865 hasRelatedWork W2083483287 @default.
• W2073996865 hasRelatedWork W2133675782 @default.
• W2073996865 hasRelatedWork W2234839489 @default.
• W2073996865 hasRelatedWork W2372105550 @default.
• W2073996865 hasRelatedWork W2384611142 @default.
• W2073996865 hasRelatedWork W2416632858 @default.
• W2073996865 hasRelatedWork W3030229032 @default.
• W2073996865 hasRelatedWork W4232243950 @default.
• W2073996865 hasRelatedWork W2948058885 @default.
• W2073996865 isParatext "false" @default.
• W2073996865 isRetracted "false" @default.
• W2073996865 magId "2073996865" @default.
• W2073996865 workType "article" @default.